Senti Biosciences, Inc.
SNTI
Revenue
0.00
0.000.00%
3 Months ChangeAssets
86.91M
▼-15.27M▼-14.95%
3 Months ChangeLiabilities
42.77M
▼-3.33M▼-7.22%
3 Months ChangeFree Cash Flow
-11.70M
▲11.11M▲48.72%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-25
Form 8-K
ID: 0001854270-24-000108
2024-09-27
Form 8-K
ID: 0001854270-24-000105
2024-08-13
Form 10-Q
ID: 0001854270-24-000101
2024-08-13
Form 8-K
ID: 0001854270-24-000099
2024-07-17
Form 8-K
ID: 0001854270-24-000094
2024-07-16
Form 8-K
ID: 0001854270-24-000091
2024-07-12
Form 8-K
ID: 0001854270-24-000081
2024-05-17
Form 8-K
ID: 0001854270-24-000061
2024-05-09
Form 10-Q
ID: 0001854270-24-000052
2024-05-09
Form 8-K
ID: 0001854270-24-000050